Both in Pharmaceuticals
Xilio Therapeutics vs Heron Therapeutics
Over the past year XLO returned −27.1% and HRTX returned −75.9%; their daily moves had a correlation of -0.04.
XLO −27.1% HRTX −75.9%Growth of $1, one year, split-adjusted
| Metric | XLO | HRTX |
|---|---|---|
| Price | $8.68 | $0.2847 |
| Market cap | $57.1M | $54.1M |
| Today | +8.64% | −3.52% |
| 1 month | −4.7% | −23.1% |
| 6 months | +12.6% | −76.9% |
| Year to date | −3.2% | −78.1% |
| 1 year | −22.2% | −75.5% |
| Revenue growth (YoY) | +131.2% | +1.3% |
| Gross margin | 100.0% | 69.3% |
| Net margin | −34.1% | −14.6% |
| P/E (TTM) | — | — |
| Price / sales | 0.9× | 0.4× |
| Net cash | $136.0M | -$100.0M |
| Dividend yield | — | — |
| Volatility (60d) | 38.3% | 87.6% |
| Short % of float | 10.1% | 25.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).